Avinger to Announce Third Quarter Results on November 11, 2021

Rhea-AI Summary

Avinger, Inc. (NASDAQ:AVGR), a medical device company, is set to release its third quarter 2021 financial results on November 11, 2021, after market close. A conference call will follow at 1:30 pm PT / 4:30 pm ET, accessible via phone or live webcast on the company’s investor relations page. Avinger specializes in intravascular imaging systems for diagnosing and treating Peripheral Artery Disease (PAD), which impacts millions globally. The company aims to transform vascular disease treatment through its Lumivascular platform.

Positive

• Avinger is the first and only company to market an intravascular image-guided catheter-based system for PAD.
• PAD affects over 12 million people in the U.S. and 200 million worldwide, indicating a significant market.

Negative

• None.

REDWOOD CITY, CA / ACCESSWIRE / October 29, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it will release its financial results for the third quarter 2021 after the close of trading on Thursday, November 11, 2021. The Company will host a conference call beginning at 1:30 pm PT/4:30 pm ET.

To join the call by telephone, please dial +1-973-528-0011 and use passcode 674853. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at http://www.avinger.com.

A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and Tigereye^TM family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:

Mark Weinswig
Chief Financial Officer
Avinger, Inc.
(650) 241-7916
ir@avinger.com

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View source version on accesswire.com:
https://www.accesswire.com/670254/Avinger-to-Announce-Third-Quarter-Results-on-November-11-2021

FAQ

When will Avinger announce its third quarter financial results for 2021?

Avinger will announce its third quarter financial results on November 11, 2021.

What time is Avinger's conference call scheduled for?

The conference call is scheduled for 1:30 pm PT / 4:30 pm ET on November 11, 2021.

How can I access Avinger's conference call?

You can join the conference call by dialing +1-973-528-0011 and using passcode 674853 or by visiting the company's investor relations page for a live webcast.

What is Avinger known for?

Avinger is known for its Lumivascular platform, which includes the first intravascular image-guided system for diagnosing and treating Peripheral Artery Disease.